| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
26,131 |
4,024 |
$1.94M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
4,488 |
1,099 |
$184K |
| 97161 |
|
1,973 |
1,259 |
$141K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,098 |
1,885 |
$132K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,296 |
952 |
$114K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,653 |
2,443 |
$69K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,639 |
2,417 |
$57K |
| 97162 |
|
624 |
381 |
$47K |
| 92557 |
|
1,317 |
832 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,738 |
6,241 |
$45K |
| 80053 |
Comprehensive metabolic panel |
12,230 |
10,250 |
$43K |
| 92567 |
|
2,613 |
1,659 |
$37K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
665 |
651 |
$35K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,204 |
5,592 |
$22K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,742 |
10,524 |
$21K |
| 92579 |
|
959 |
614 |
$20K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,655 |
1,523 |
$19K |
| 87070 |
|
4,999 |
4,710 |
$13K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
479 |
446 |
$13K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
755 |
689 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
496 |
450 |
$12K |
| 80061 |
Lipid panel |
5,666 |
5,346 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
879 |
779 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
899 |
650 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,410 |
4,186 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
791 |
741 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
710 |
467 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,086 |
1,014 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,271 |
2,081 |
$7K |
| 87186 |
|
1,904 |
1,690 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,314 |
2,156 |
$6K |
| V5241 |
Dispensing fee, monaural hearing aid, any type |
28 |
28 |
$6K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
601 |
588 |
$6K |
| 87800 |
|
817 |
740 |
$5K |
| 80074 |
|
261 |
244 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
39 |
37 |
$5K |
| 82607 |
|
1,496 |
1,369 |
$5K |
| 87653 |
|
386 |
337 |
$5K |
| 84439 |
|
2,120 |
1,957 |
$5K |
| 86038 |
|
450 |
404 |
$5K |
| 87088 |
|
1,403 |
1,297 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
93 |
54 |
$5K |
| 87522 |
Neg quan hep c or qual rna |
109 |
103 |
$4K |
| 82728 |
|
1,416 |
1,317 |
$4K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
159 |
157 |
$4K |
| 87340 |
|
746 |
687 |
$3K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
227 |
64 |
$3K |
| 82746 |
|
680 |
645 |
$3K |
| 86901 |
|
1,502 |
1,361 |
$3K |
| 73564 |
|
279 |
258 |
$3K |
| 73610 |
|
230 |
206 |
$3K |
| 86696 |
|
127 |
112 |
$3K |
| 84466 |
|
1,223 |
1,098 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
62 |
56 |
$3K |
| 84702 |
|
810 |
672 |
$3K |
| 73630 |
|
279 |
257 |
$3K |
| 87081 |
|
1,324 |
1,226 |
$3K |
| 86336 |
|
177 |
174 |
$3K |
| 84403 |
|
311 |
267 |
$3K |
| 85027 |
|
1,522 |
1,293 |
$2K |
| 86592 |
|
1,543 |
1,396 |
$2K |
| 72110 |
|
142 |
138 |
$2K |
| 86141 |
|
328 |
298 |
$2K |
| 85610 |
|
1,524 |
902 |
$2K |
| 83516 |
|
153 |
108 |
$2K |
| 83540 |
|
1,295 |
1,176 |
$2K |
| 73110 |
|
178 |
162 |
$2K |
| 86850 |
|
1,538 |
1,365 |
$2K |
| 86695 |
|
132 |
113 |
$2K |
| 81001 |
|
2,327 |
1,903 |
$2K |
| 84153 |
|
396 |
382 |
$2K |
| 82105 |
|
232 |
227 |
$2K |
| 84481 |
|
602 |
556 |
$2K |
| 83735 |
|
1,034 |
743 |
$2K |
| 74018 |
|
140 |
127 |
$1K |
| 80076 |
|
548 |
511 |
$1K |
| 84270 |
|
97 |
83 |
$1K |
| 86318 |
|
180 |
142 |
$1K |
| 86762 |
|
726 |
661 |
$1K |
| 73030 |
|
125 |
121 |
$1K |
| 86900 |
|
1,549 |
1,369 |
$1K |
| 81003 |
|
1,529 |
1,432 |
$1K |
| 80306 |
|
253 |
228 |
$1K |
| 82043 |
|
617 |
599 |
$1K |
| 86255 |
|
197 |
170 |
$1K |
| 82570 |
|
866 |
750 |
$1K |
| 73502 |
|
75 |
68 |
$1K |
| 73130 |
|
119 |
106 |
$1K |
| 86140 |
|
736 |
583 |
$960.92 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
12 |
12 |
$863.59 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
38 |
38 |
$849.08 |
| 87486 |
|
37 |
37 |
$826.24 |
| 86431 |
|
350 |
297 |
$769.52 |
| 97165 |
|
74 |
50 |
$767.04 |
| V5264 |
Ear mold/insert, not disposable, any type |
13 |
12 |
$752.73 |
| 85652 |
|
974 |
800 |
$726.42 |
| 87581 |
|
37 |
37 |
$714.82 |
| 82950 |
|
691 |
651 |
$699.99 |
| 87205 |
|
813 |
679 |
$695.99 |
| 82784 |
|
112 |
89 |
$676.35 |
| 83001 |
|
97 |
83 |
$637.55 |
| 82677 |
|
164 |
160 |
$627.35 |
| 87899 |
|
76 |
48 |
$526.71 |
| 92582 |
|
23 |
14 |
$470.65 |
| 85007 |
|
415 |
296 |
$394.54 |
| 84550 |
|
321 |
288 |
$372.33 |
| 83525 |
|
141 |
133 |
$342.35 |
| 83690 |
|
191 |
173 |
$335.16 |
| 87209 |
|
34 |
29 |
$286.13 |
| 87045 |
|
83 |
58 |
$282.32 |
| 84703 |
|
100 |
92 |
$261.78 |
| 80164 |
|
74 |
66 |
$234.07 |
| 82274 |
|
80 |
73 |
$210.45 |
| 73140 |
|
31 |
30 |
$202.42 |
| 87210 |
|
166 |
149 |
$200.67 |
| 83002 |
|
64 |
53 |
$172.54 |
| 82550 |
|
96 |
92 |
$166.56 |
| 82103 |
|
21 |
12 |
$137.92 |
| 73590 |
|
14 |
13 |
$135.98 |
| 82150 |
|
75 |
66 |
$134.38 |
| 80050 |
General health panel |
29 |
12 |
$127.80 |
| 86706 |
|
12 |
12 |
$123.34 |
| 87449 |
|
33 |
32 |
$122.92 |
| 88142 |
|
55 |
54 |
$117.36 |
| 82947 |
|
85 |
76 |
$88.30 |
| 82248 |
|
51 |
41 |
$76.43 |
| 87807 |
|
18 |
16 |
$69.03 |
| 84146 |
|
15 |
14 |
$65.48 |
| 87177 |
|
33 |
29 |
$63.09 |
| 36415 |
Collection of venous blood by venipuncture |
1,495 |
1,414 |
$56.19 |
| 87335 |
|
19 |
19 |
$53.48 |
| 83880 |
|
14 |
12 |
$51.01 |
| 86003 |
|
12 |
12 |
$48.73 |
| 85730 |
|
16 |
13 |
$25.82 |
| 86308 |
|
13 |
12 |
$11.82 |
| 89055 |
|
14 |
14 |
$7.25 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
148 |
104 |
$0.00 |
| 0065U |
|
166 |
153 |
$0.00 |
| G0202 |
Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed |
12 |
12 |
$0.00 |